Saint-Petersburg, Russia

Mariia Sergeevna Mishina

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariia Sergeevna Mishina. Retrieved from https://idiyas.com/inventor/mariia-sergeevna-mishina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariia Sergeevna Mishina: Innovator in CDK8/19 Inhibitors

Introduction

Mariia Sergeevna Mishina is a prominent inventor based in St. Petersburg, Russia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of CDK8/19 inhibitors. Her work is crucial for advancing treatments for various diseases and disorders.

Latest Patents

Mishina holds a patent for novel compounds that act as CDK8/19 inhibitors. This invention relates to a pharmaceutical composition comprising these compounds, which are designed to be used as medicine for treating specific health conditions. The patent highlights her innovative approach to addressing medical challenges.

Career Highlights

Throughout her career, Mariia has demonstrated a strong commitment to research and development in the pharmaceutical industry. Her focus on creating effective treatments showcases her dedication to improving patient outcomes. The impact of her work is evident in the advancements made in the field.

Collaborations

Mishina has collaborated with notable colleagues, including Aleksei Leonidovich Mindich and Anna Jur'evna Chestnova. These partnerships have enhanced her research efforts and contributed to the successful development of her patented compounds.

Conclusion

Mariia Sergeevna Mishina is a trailblazer in the field of pharmaceutical innovation, particularly with her work on CDK8/19 inhibitors. Her contributions are vital for the ongoing advancement of medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…